Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Denekamp

Showing results (161-170 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 2000
Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiationO E Jonsson, L Bjermer, J Denekamp, et al.
The British Journal of Radiology|October 1, 1980
Misonidazole in fractionated radiotherapy: are many small fractions best?J Denekamp, N J McNally, J F Fowler, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
The effect of vinca alkaloids on tumour blood flowS A Hill, S J Lonergan, J Denekamp, et al.
Radiation Research|March 1, 1970
Survival of mouse skin epithelial cells following single and divided doses of x-raysE W Emery, J Denekamp, M M Ball, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1989
The fractionated response of mouse stroma after X-rays and neutrons: influence of early vs late expression of damageS A Hill, K A Smith, K B Williams, et al.
British Journal of Cancer|July 1, 1982
In vivo assessment of basic 2-nitroimidazole radiosensitizersM V Williams, J Denekamp, A I Minchinton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administrationM V Williams, J Denekamp, A I Minchinton, et al.
The British Journal of Radiology|April 1, 1978
Hypoxic cell sensitization by misonidazole in vivo and in vitroN J McNally, J Denekamp, P W Sheldon, et al.
British Journal of Cancer|March 1, 1988
Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumoursK A Smith, S A Hill, A C Begg, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1976
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutronsJ F Fowler, P W Sheldon, J Denekamp, et al.
Pageof 22

Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|January 1, 2000
Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiationO E Jonsson, L Bjermer, J Denekamp, et al.
The British Journal of Radiology|October 1, 1980
Misonidazole in fractionated radiotherapy: are many small fractions best?J Denekamp, N J McNally, J F Fowler, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
The effect of vinca alkaloids on tumour blood flowS A Hill, S J Lonergan, J Denekamp, et al.
Radiation Research|March 1, 1970
Survival of mouse skin epithelial cells following single and divided doses of x-raysE W Emery, J Denekamp, M M Ball, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1989
The fractionated response of mouse stroma after X-rays and neutrons: influence of early vs late expression of damageS A Hill, K A Smith, K B Williams, et al.
British Journal of Cancer|July 1, 1982
In vivo assessment of basic 2-nitroimidazole radiosensitizersM V Williams, J Denekamp, A I Minchinton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administrationM V Williams, J Denekamp, A I Minchinton, et al.
The British Journal of Radiology|April 1, 1978
Hypoxic cell sensitization by misonidazole in vivo and in vitroN J McNally, J Denekamp, P W Sheldon, et al.
British Journal of Cancer|March 1, 1988
Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumoursK A Smith, S A Hill, A C Begg, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1976
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutronsJ F Fowler, P W Sheldon, J Denekamp, et al.
Pageof 22